YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Network Toxicology for the Cardiovascular Toxicity Analysis of Tyrosine Kinase Inhibitors

dc.authorscopusid 57201195704
dc.contributor.author Karakuş, F.
dc.date.accessioned 2025-05-10T16:55:04Z
dc.date.available 2025-05-10T16:55:04Z
dc.date.issued 2024
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Karakuş F., Van Yuzuncu Yil University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Van, 65080, Turkey en_US
dc.description.abstract Objective: This study aims to explore potential molecular mechanisms and targets of cardiovascular toxicities caused by tyrosine kinase inhibitors. Therefore, toxicogenomic data mining was conducted focusing on sunitinib, sorafenib, pazopanib, axitinib, and their associations with cardiovascular diseases. Material and Method: Common genes between tyrosine kinase inhibitors and cardiovascular diseases were uncovered via comparative toxicogenomic databases. Additionally, protein-protein and gene-gene interactions were identified using STRING and GeneMANIA, respectively. Subsequently, hub proteins associated with tyrosine kinase inhibitor-induced cardiovascular diseases were determined through Metascape. Transcription factors and microRNAs related to this toxicity were identified using ChEA3 and MIENTURNET, respectively. Finally, gene ontology enrichment analysis and the most associated molecular pathways were identified using the DAVID database and Metascape, respectively. Result and Discussion: Toxicogenomic data mining revealed six genes common between tyrosine kinase inhibitors and cardiovascular diseases, with five of these genes (FLT1, FLT4, KDR, MAPK1, and MAPK3) identified as hub genes. Physical interaction was dominant among these hub genes (77.64%). Sunitinib, sorafenib, pazopanib, and axitinib generally downregulated the activities of these proteins. SOX17 and SOX18 were prominent among transcription factors, while hsa-miR-199a-3p was the most important microRNA associated with this toxicity. Moreover, the Ras signaling pathway was mostly associated with tyrosine kinase inhibitor-induced cardiovascular toxicities. These findings make a substantial contribution to understanding the processes underlying cardiovascular diseases induced by sunitinib, sorafenib, pazopanib, and axitinib. They also reveal novel potential therapeutic targets, including genes, proteins, transcription factors, microRNAs, and pathways. © 2024 University of Ankara. All rights reserved. en_US
dc.identifier.doi 10.33483/jfpau.1478733
dc.identifier.endpage 939 en_US
dc.identifier.issn 2564-6524
dc.identifier.issue 3 en_US
dc.identifier.scopus 2-s2.0-85207622925
dc.identifier.scopusquality Q4
dc.identifier.startpage 929 en_US
dc.identifier.uri https://doi.org/10.33483/jfpau.1478733
dc.identifier.uri https://hdl.handle.net/20.500.14720/3364
dc.identifier.volume 48 en_US
dc.identifier.wosquality N/A
dc.institutionauthor Karakuş, F.
dc.language.iso en en_US
dc.publisher University of Ankara en_US
dc.relation.ispartof Ankara Universitesi Eczacilik Fakultesi Dergisi en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Cardiovascular Disease en_US
dc.subject In Silico Data Mining en_US
dc.subject Tyrosine Kinase Inhibitors en_US
dc.title Network Toxicology for the Cardiovascular Toxicity Analysis of Tyrosine Kinase Inhibitors en_US
dc.type Article en_US

Files